Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia

FLT3 is frequently mutated in acute myeloid leukemia (AML), but resistance has limited the benefit of tyrosine kinase inhibitors (TKI). We demonstrate that statins can impair FLT3 glycosylation, thus leading to loss of surface expression and induction of cell death, as well as mitigation of TKI resi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Williams, Allen B., Li, Li, Nguyen, Bao, Brown, Patrick, Levis, Mark, Small, Donald
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Myeloid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3471516/
https://ncbi.nlm.nih.gov/pubmed/22927251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-01-403493
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars